Loading clinical trials...
Loading clinical trials...
The Role of Contrast Enhanced Endoscopic Ultrasound for Evaluation of Pancreas Lesions
Conditions
Interventions
EUS enhanced with contrast to evaluate pancreas
Locations
1
United States
Cedars-Sinai Medical Center
Los Angeles, California, United States
Start Date
February 26, 2020
Primary Completion Date
December 31, 2025
Completion Date
December 31, 2025
Last Updated
December 20, 2023
NCT04195347
NCT07267169
NCT06729996
NCT06651580
NCT06553651
NCT04485286
Lead Sponsor
Cedars-Sinai Medical Center
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions